Long-term conclusions rely on extrapolation Marie Spreckley, obesity researcher and public health nutritionist at the University of Cambridge in England, who was not involved in the study, cautioned that the papers long-term conclusions rely on modeled projections, rather than observed data, as the follow-up period for stopping treatment with newer medicines is limited to about 12 months
The bulk of current legal action is focused on semaglutide-based drugs, especially those used off-label or for weight loss
The MDL 3094, initially overseen by District Judge Gene E.K
Previous results indicate that TNC is downregulated by GLP-1RA treatment and correlates with incident CVD 43 , suggesting that TNC may act as a mediator, with downregulation contributing to the cardiovascular-protective effects of GLP-1RAs
No, Rybelsus is not approved for non-diabetic weight loss or use in people without Type 2 Diabetes